Kyverna Therapeutics, Inc. (KYTX)
NASDAQ·Healthcare·Biotechnology
$7.16
-4.41%
Mkt Cap $450.49M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$30.75
Range $25.00 – $33.00
Implied Upside
+329.5%
Consensus $30.75 vs current $7.16
NASDAQ·Healthcare·Biotechnology
$7.16
-4.41%
Mkt Cap $450.49M
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$30.75
Range $25.00 – $33.00
+329.5%
Consensus $30.75 vs current $7.16